Flu Stocks Print
By Staff and Wire Reports   

Companies with Certified Existing Treatments for Swine Flu

Gilead Sciences, Inc. (NASDAQ:GILD)
Roche Holding Ltd. (OTC:RHHBY)
Product: Tamiflu (oseltamivir)

GlaxoSmithKline plc (NYSE:GSK) /
Biota Holdings Ltd.(ASX:BTA)
Product: Relenza (zanamivir)

Baxter International Inc. (NYSE: BAX)
A(H1N1) vaccine using its Vero cell culture technology

Novartis AG (NYSE:NVS)
Product: Influenza A(H1N1) vaccine using Cell-based manufacturing technology

Companies with Potential Treatments for Swine Flu

CEL-SCI Corporation (Amex: CVM)
Product: proprietary L.E.A.P.S. technology (Ligand Epitope Antigen Presentation System)

Companies with Potential Vaccines
for Swine Flu

Biota Holdings Ltd.(ASX:BTA) /
Daiichi Sankyo
Product: CS-8958

BioCryst Pharmaceuticals,Inc. (NASDAQ:BCRX)
Product: Peramivir Intravenous

Novavax, Inc. (NASDAQ:NVAX)
Product: Swine Flu Vaccines
using Virus-like particle (VLP) technology

Inovio Biomedical Corporation (NYSE Amex:INO)
Product: SynCon™ H1N1 influenza DNA vaccines

Vical Incorporated(Public, NASDAQ:VICL)
Patented DNA delivery technology

Sinovac Biotech Ltd. (Amex: SVA)
Product: Panflu(TM)

Wyeth (NYSE: WYE)
Product: PCV13 or Prevnar 13

MedImmune / AstraZeneca PLC (NYSE:AZN)
Product: needle-free, nasal spray swine flu vaccine by using Live Attenuated Influenza Vaccine (LAIV) technology

Sanofi-Aventis SA (NYSE:SNY)
Product: Swine Flu Vaccine

Companies with Adjuvants
for Swine Flu Vaccines

Antigenics, Inc. (NASDAQ:AGEN)
Product: QS-21 Stimulon

Hemispherx Biopharma (AMEX:HEB)
Product: Ampligen

Other Technologies
Which Combat H1N1

Oculus Innovative Sciences, Inc.
Microcyn® Technology platform

"Featured Content" profiles are meant to provide awareness of these companies to investors in the small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!

blog comments powered by Disqus